Analysts at Morgan Stanley raised the price target of Alexion Pharmaceuticals (NASDAQ: ALXN) to $121.00 on Tuesday. This is up from the earlier $120.00. The research firm further announces the rating of “equal weight” to NASDAQ: ALXN stocks. Wall Street Analysts Rates NASDAQ: ALXN Stocks At “Buy” Several Wall Street analysts...
Analysts at Morgan Stanley trimmed the price target of Amgen (NASDAQ: AMGN) to $273.00 on Tuesday. This is down from the earlier $281.00. Morgan Stanley analysts issued a note to several investors informing this cut in Amgen’s PT. The research firm further announces the rating of “overweight” to NASDAQ:...
Five Wall Street analysts covering NYSE: MCB reports a “Hold’ rating consensus on Metropolitan Bank Holding Corp this quarter. Out of the five research firms, one posted a “sell” rating and three announced a “buy” rating making up the average consensus of a “hold” rating. Several analysts suggest that the...
Qiagen (NYSE: QGEN) posted an update on its Q3 earnings guidance this Tuesday. The EPS guidance stands at $0.58 for this quarter beating the Thomas Reuters estimate of $0.56. Revenue stands at $481.3 million as opposed to the consensus estimate of $462.67million. NYSE: QGEN Quarterly Earnings Report Estimates NYSE: QGEN posted...
According to reports by Benzinga, a research report on Tuesday suggested that Morgan Stanley increased the price target on Ascendis Pharma A/S (NASDAQ:ASND) from $179.00 to $194.00. The company’s stock has received an ‘overweight’ rating from the brokerage. The price target set by Morgan Stanley indicates a 21.33% potential...
Morgan Stanley stock analysts’ dropped the price target on AVROBIO (NASDAQ:AVRO) from $35.00 to $34.00 suggested a research note that was issued to investors on Tuesday, according to Benzinga. The company’s stock has an ‘overweight’ rating, currently. The new price target indicates a 124.72% potential shift from the current...
Investment analysts at Zelman & Associates lowered the rating of Meritage Homes (NYSE:MTH) from ‘buy’ to ‘hold’ in a research note given to investors and clients on Tuesday, as per the reports of The Fly.  Meritage Homes (NYSE:MTH)- Analysts’ Opinion Several comments were bestowed upon the company by various brokerages. In...
As per the Fly, stock analysts at Zelman & Associates Lowered the rating of PulteGroup (NYSE:PHM) from ‘buy’ to ‘hold’ in a research note issued to investors and clients on Tuesday. PulteGroup (NYSE:PHM)- Analysts’ Opinion Various research reports have covered PulteGroup (NYSE:PHM). In a research report issued on Thursday, 8th August,...
NASDAQ:QURE went some really unusual trading options last Monday when traders bought close to 618 stocks on the put option. This was an increase of around 758% when compared to the 72 put options’ value. There have been several reports issued on NASDAQ:QURE by research firms. Stifel Nicolaus did...
Nomura reissued the ‘buy’ rating that it had already given to NYSE:EDU on Tuesday, according to AnalystRatings. Most of the other research analysts, too, issued several reports about this stock. Goldman Sachs Group decided to lift the target price for the shares of NYSE:EDU from $145, to $149, while...